GXO Logistics Appointed by NHS England for Bowel Cancer Screening Services
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 30 2026
0mins
Should l Buy GXO?
GXO Logistics continued its expansion in healthcare logistics with the announcement of its appointment by NHS England as the managed service provider for the continued provision of Fecal Immunochemical Test home testing for eligible participants in the bowel cancer screening program across England. As part of the agreement, GXO will manage the supply and distribution of FIT kits working with partners, MAST and RDi.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GXO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GXO
Wall Street analysts forecast GXO stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 55.990
Low
58.00
Averages
66.08
High
80.00
Current: 55.990
Low
58.00
Averages
66.08
High
80.00
About GXO
GXO Logistics, Inc. is a contract logistics provider. The Company provides its customers with value-added warehousing and distribution, order fulfillment, e-commerce, reverse logistics and other supply chain services to deliver technology-enabled customized solutions. It offers its technology in three areas: labor and inventory management productivity, intelligent warehouse automation and predictive analytics, all of which are integrated through its warehouse management platform. The Company has three reporting units: Americas and Asia-Pacific; United Kingdom; and Ireland and Continental Europe. It operates approximately 1,030 facilities worldwide, totaling 218 million square feet of space, primarily on behalf of large corporations that have outsourced their warehousing, distribution, and other related activities to the Company. It serves a range of customers in various industries, including grocery, retail and manufacturing, consumer goods, healthcare, defense, industrial, and energy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
QXO CEO's Transparent Goals and Market Response
- Clear Market Goals: QXO CEO Brad Jacobs aims to reach $50 billion in annual revenue over the next decade through strategic acquisitions and organic growth, demonstrating a commitment to consolidating the $800 billion building products distribution industry.
- Significant Revenue Growth: Following the acquisition of Beacon Roofing Supply, QXO's revenue surged from $57 million to $6.8 billion last year, indicating initial success in its acquisition strategy and laying a foundation for future growth.
- Stock Price Volatility: Although QXO shares fell 18.9% in March, the absence of new acquisition announcements does not signify bad news; rather, it presents a buying opportunity for investors, reflecting market anticipation for future acquisitions.
- Cautious Acquisition Strategy: Jacobs' decision to not raise the bid for GMS, despite potential bidding wars, underscores his commitment to shareholder interests, and investors should trust his ability to identify new profitable acquisitions, with the March pullback offering a favorable entry point for those optimistic about QXO's future.
See More
GXO Expands Logistics Footprint in Canada with New Distribution Center
- New Distribution Center: GXO has opened a new distribution center in Mississauga, Ontario, expanding its North American footprint and deepening its long-standing partnership with Pandora, the world's largest jewelry brand.
- Technology-Driven Efficiency: The new facility features advanced technology solutions, including lighted picking systems for high-precision order assembly and video capture for high-value shipments, enhancing order accuracy and throughput, thereby optimizing overall network efficiency.
- Supporting Omnichannel Growth: By localizing fulfillment in the Canadian market, GXO supports Pandora's accelerating omnichannel growth, reducing cross-border complexity and improving the speed and reliability of customer experiences, which enhances supply chain agility and resilience.
- Ongoing Investment and Expansion: The establishment of this new center reflects GXO's continued investment in scalable, tech-enabled logistics solutions, further solidifying its operational network in North America to meet the rapidly growing demand for e-commerce.
See More
GXO Logistics Expands Healthcare Logistics Services
- Partnership Announcement: GXO Logistics has been appointed by NHS England as the managed service provider for fecal immunochemical test home testing, aimed at enhancing accessibility and convenience in the bowel cancer screening program across the UK.
- Supply Chain Management: Under the agreement, GXO will manage the supply and distribution of FIT kits, leveraging advanced logistics capabilities and a deep understanding of healthcare supply requirements to ensure efficient service delivery.
- Positive Market Reaction: Shares of GXO rose 2.7% in premarket trading on Monday, reflecting market confidence in the company's ongoing investment and rapid growth in the healthcare sector.
- Enhanced Industry Impact: GXO's solutions are purpose-built for the complex and highly regulated needs of healthcare supply chains, and this partnership further solidifies its significant role in the UK economy and the NHS.
See More
GXO Appointed by NHS England for National Bowel Cancer Testing Kits Management
- Strategic Partnership: GXO has been appointed by NHS England as the managed service provider for the bowel cancer screening program, responsible for the supply and distribution of FIT home testing kits, marking a significant expansion and investment in healthcare logistics.
- Market Impact: This collaboration will leverage GXO's resources alongside top partners like MAST and RDi to ensure eligible participants receive timely testing, enhancing NHS's efficiency and coverage in early bowel cancer screening.
- Alignment with Health Plans: The agreement aligns with the NHS 10 Year Health Plan, aiming to shift care from hospitals to community settings while emphasizing the importance of prevention, thereby improving early detection rates and health outcomes.
- Technological Edge: By combining advanced logistics capabilities with a deep understanding of healthcare supply chain needs, GXO will support NHS England in making screening services more accessible and convenient, further promoting public health accessibility and convenience.
See More
Market Sell-Offs Present Buying Opportunities
- Hexcel's Growth Potential: Hexcel is projected to achieve double-digit sales growth through 2028, with earnings growing at 17.1% annually and free cash flow (FCF) at 25% annually, indicating strong long-term growth prospects amid a recovery in aircraft production.
- GXO Logistics Market Outlook: Despite facing revenue retraction in 2023 and 2024, GXO anticipates mid-single-digit organic growth by 2026, reflecting robust long-term growth potential as e-commerce logistics demand rebounds.
- Aerospace Manufacturing Demand: Hexcel's advanced composites for Boeing and Airbus significantly reduce fuel costs and emissions, with each Boeing 777X potentially generating $2 million in revenue, further solidifying its market position in the aerospace sector.
- Investment Value Assessment: GXO's FCF guidance trades at 18.3 times the midpoint for 2026, indicating strong value under robust long-term growth opportunities, while Hexcel's valuation at 31 times suggests optimism for its long-term growth despite higher near-term costs.
See More
Investment Potential of Hexcel and GXO Logistics
- Hexcel's Growth Prospects: Hexcel supplies advanced lightweight composites to Boeing and Airbus, with projected sales growth at a double-digit annual rate, earnings increasing by 17.1% annually, and free cash flow (FCF) growing at 25% annually through 2028, indicating significant benefits from the aerospace industry's recovery.
- Market Demand in Aviation: The introduction of new aircraft models like the Boeing 777X and Airbus A350 allows Hexcel to generate $2 million to $5 million in revenue per aircraft, underscoring its critical role and future profitability potential in the aerospace manufacturing sector.
- GXO Logistics Market Dynamics: As a leader in e-commerce logistics warehousing, GXO benefited during the pandemic, and despite facing revenue retraction in 2023 and 2024, it is expected to achieve mid-single-digit organic growth by 2026, demonstrating resilience in its long-term growth outlook.
- Technology-Driven Logistics Outsourcing: With increasing automation, robotics, and artificial intelligence in warehousing, GXO's business model is becoming more competitive, with projected revenue growth at a mid-single-digit rate, earnings growing at 10% annually, and FCF increasing by 18% annually.
See More
QXO CEO's Transparent Goals and Market Response
- Clear Market Goals: QXO CEO Brad Jacobs aims to reach $50 billion in annual revenue over the next decade through strategic acquisitions and organic growth, demonstrating a commitment to consolidating the $800 billion building products distribution industry.
- Significant Revenue Growth: Following the acquisition of Beacon Roofing Supply, QXO's revenue surged from $57 million to $6.8 billion last year, indicating initial success in its acquisition strategy and laying a foundation for future growth.
- Stock Price Volatility: Although QXO shares fell 18.9% in March, the absence of new acquisition announcements does not signify bad news; rather, it presents a buying opportunity for investors, reflecting market anticipation for future acquisitions.
- Cautious Acquisition Strategy: Jacobs' decision to not raise the bid for GMS, despite potential bidding wars, underscores his commitment to shareholder interests, and investors should trust his ability to identify new profitable acquisitions, with the March pullback offering a favorable entry point for those optimistic about QXO's future.
See More
GXO Expands Logistics Footprint in Canada with New Distribution Center
- New Distribution Center: GXO has opened a new distribution center in Mississauga, Ontario, expanding its North American footprint and deepening its long-standing partnership with Pandora, the world's largest jewelry brand.
- Technology-Driven Efficiency: The new facility features advanced technology solutions, including lighted picking systems for high-precision order assembly and video capture for high-value shipments, enhancing order accuracy and throughput, thereby optimizing overall network efficiency.
- Supporting Omnichannel Growth: By localizing fulfillment in the Canadian market, GXO supports Pandora's accelerating omnichannel growth, reducing cross-border complexity and improving the speed and reliability of customer experiences, which enhances supply chain agility and resilience.
- Ongoing Investment and Expansion: The establishment of this new center reflects GXO's continued investment in scalable, tech-enabled logistics solutions, further solidifying its operational network in North America to meet the rapidly growing demand for e-commerce.
See More
GXO Logistics Expands Healthcare Logistics Services
- Partnership Announcement: GXO Logistics has been appointed by NHS England as the managed service provider for fecal immunochemical test home testing, aimed at enhancing accessibility and convenience in the bowel cancer screening program across the UK.
- Supply Chain Management: Under the agreement, GXO will manage the supply and distribution of FIT kits, leveraging advanced logistics capabilities and a deep understanding of healthcare supply requirements to ensure efficient service delivery.
- Positive Market Reaction: Shares of GXO rose 2.7% in premarket trading on Monday, reflecting market confidence in the company's ongoing investment and rapid growth in the healthcare sector.
- Enhanced Industry Impact: GXO's solutions are purpose-built for the complex and highly regulated needs of healthcare supply chains, and this partnership further solidifies its significant role in the UK economy and the NHS.
See More
GXO Appointed by NHS England for National Bowel Cancer Testing Kits Management
- Strategic Partnership: GXO has been appointed by NHS England as the managed service provider for the bowel cancer screening program, responsible for the supply and distribution of FIT home testing kits, marking a significant expansion and investment in healthcare logistics.
- Market Impact: This collaboration will leverage GXO's resources alongside top partners like MAST and RDi to ensure eligible participants receive timely testing, enhancing NHS's efficiency and coverage in early bowel cancer screening.
- Alignment with Health Plans: The agreement aligns with the NHS 10 Year Health Plan, aiming to shift care from hospitals to community settings while emphasizing the importance of prevention, thereby improving early detection rates and health outcomes.
- Technological Edge: By combining advanced logistics capabilities with a deep understanding of healthcare supply chain needs, GXO will support NHS England in making screening services more accessible and convenient, further promoting public health accessibility and convenience.
See More
Market Sell-Offs Present Buying Opportunities
- Hexcel's Growth Potential: Hexcel is projected to achieve double-digit sales growth through 2028, with earnings growing at 17.1% annually and free cash flow (FCF) at 25% annually, indicating strong long-term growth prospects amid a recovery in aircraft production.
- GXO Logistics Market Outlook: Despite facing revenue retraction in 2023 and 2024, GXO anticipates mid-single-digit organic growth by 2026, reflecting robust long-term growth potential as e-commerce logistics demand rebounds.
- Aerospace Manufacturing Demand: Hexcel's advanced composites for Boeing and Airbus significantly reduce fuel costs and emissions, with each Boeing 777X potentially generating $2 million in revenue, further solidifying its market position in the aerospace sector.
- Investment Value Assessment: GXO's FCF guidance trades at 18.3 times the midpoint for 2026, indicating strong value under robust long-term growth opportunities, while Hexcel's valuation at 31 times suggests optimism for its long-term growth despite higher near-term costs.
See More
Investment Potential of Hexcel and GXO Logistics
- Hexcel's Growth Prospects: Hexcel supplies advanced lightweight composites to Boeing and Airbus, with projected sales growth at a double-digit annual rate, earnings increasing by 17.1% annually, and free cash flow (FCF) growing at 25% annually through 2028, indicating significant benefits from the aerospace industry's recovery.
- Market Demand in Aviation: The introduction of new aircraft models like the Boeing 777X and Airbus A350 allows Hexcel to generate $2 million to $5 million in revenue per aircraft, underscoring its critical role and future profitability potential in the aerospace manufacturing sector.
- GXO Logistics Market Dynamics: As a leader in e-commerce logistics warehousing, GXO benefited during the pandemic, and despite facing revenue retraction in 2023 and 2024, it is expected to achieve mid-single-digit organic growth by 2026, demonstrating resilience in its long-term growth outlook.
- Technology-Driven Logistics Outsourcing: With increasing automation, robotics, and artificial intelligence in warehousing, GXO's business model is becoming more competitive, with projected revenue growth at a mid-single-digit rate, earnings growing at 10% annually, and FCF increasing by 18% annually.
See More
